In Japan, cardiovascular system medicine sales are forecasted to experience a gradual decline from 2024 to 2028, with values decreasing from 8.3% to 6.9% of total sales. This represents a consistent downward trend reflecting a year-on-year drop in market share. Despite not having specific data from 2023 outlined here, one can reasonably infer a prior high baseline that has initiated this downward trajectory.
Future trends to watch for include:
- Increased adoption of preventative healthcare measures that could further impact traditional cardiovascular treatment sales.
- The emergence of new entrants and innovative treatments that may capture market share.
- Policy changes affecting healthcare spending and investment in chronic disease management.
